MEDICUS PHARMA LTD MDCX
$0.42
+4.0% 52w: $0.28 – $3.40
Latest 13F among current holders filed 1 month ago (May 15, 2026)
Price — last 12 months
research preview data0.281.843.40
Jun 20, 2025 Jul 2, 2026
Institutional holders
21
+0 QoQ
13F value
$6.5M
+7.6% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
1
Q1 2026
Institutional value by quarter
Number of holders
Who owns MDCX?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| Interchange Capital Partners, LLC | Other | 1.7M | $6.2M | 2.0% | +4.7% |
| Private Advisor Group, LLC | Wealth advisor | 240.1K | $110K | 0.0% | +36.8% |
| Virtu Financial LLC | Market maker | 74.0K | $34K | 0.0% | New |
| Wilmington Savings Fund Society, FSB | Diversified mechanical | 51.2K | $24K | 0.0% | Held |
| May Hill Capital, LLC | Wealth advisor | 50.6K | $23K | 0.0% | +42.1% |
| COMMONWEALTH EQUITY SERVICES, LLC | Wealth advisor | 48.1K | $22K | 0.0% | +69.0% |
| UBS Group AG | Bank broker | 40.4K | $19K | 0.0% | +205.7% |
| BlackRock, Inc. | Index provider | 37.3K | $17K | 0.0% | +8.7% |
| CITADEL ADVISORS LLC | Multistrat pod | 17.8K | $8K | 0.0% | New |
| TWO SIGMA SECURITIES, LLC | Market maker | 15.6K | $7K | 0.0% | New |
| LPL Financial LLC | Bank broker | 15.6K | $7K | 0.0% | New |
| MARATHON CAPITAL MANAGEMENT ★2 | Fundamental diversified | 15.5K | $7K | 0.0% | New |
| StoneX Group Inc. | Wealth advisor | 15.2K | $7K | 0.0% | New |
| Smithfield Trust Co | Wealth advisor | 11.5K | $5K | 0.0% | -17.3% |
| BRAVE ASSET MANAGEMENT INC | Wealth advisor | 10.0K | $5K | 0.0% | -50.0% |
| OSAIC HOLDINGS, INC. | Wealth advisor | 8.5K | $4K | 0.0% | Held |
| MORGAN STANLEY | Bank broker | 5.5K | $3K | 0.0% | -70.1% |
| JONES FINANCIAL COMPANIES LLLP | Wealth advisor | 400 | $180 | 0.0% | Held |
| Tower Research Capital LLC (TRC) | Market maker | 121 | $56 | 0.0% | New |
| WELLS FARGO & COMPANY/MN | Bank broker | 75 | $34 | 0.0% | Held |
| HAZLETT, BURT & WATSON, INC. | Other | 425 | $0 | 0.0% | Held |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding MDCX
More healthcare stocks held by institutions